Back to User profile » Dr Pablo Mandó

Papers published by Dr Pablo Mandó:


HER2-Directed Therapy in Advanced Breast Cancer: Benefits and Risks

Mandó P, Waisberg F, Pasquinelli R, Rivero S, Ostinelli A, Perazzo F

OncoTargets and Therapy 2023, 16:115-132

Published Date: 19 February 2023

High neutrophil to lymphocyte ratio and decreased CD69+NK cells represent a phenotype of high risk in early-stage breast cancer patients

Mandó P, Rizzo M, Roberti MP, Juliá EP, Pampena MB, Pérez de la Puente C, Loza CM, Ponce C, Nadal J, Coló FA, Mordoh J, Levy EM

OncoTargets and Therapy 2018, 11:2901-2910

Published Date: 17 May 2018